Physician Variation in Management of Low-Risk Prostate Cancer-Reference-Cited by-同舟云学术

Physician Variation in Management of Low-Risk Prostate Cancer

Published:2014-09-01 Issue:9 Volume:174 Page:1450
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Hoffman Karen E.¹,Niu Jiangong²,Shen Yu³,Jiang Jing³,Davis John W.⁴,Kim Jeri⁵,Kuban Deborah A.¹,Perkins George H.¹,Shah Jay B.³,Smith Grace L.¹,Volk Robert J.⁶,Buchholz Thomas A.¹,Giordano Sharon H.²,Smith Benjamin D.¹

Affiliation:

1. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston

2. Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston

3. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston

4. Department of Urology, The University of Texas MD Anderson Cancer Center, Houston

5. Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston

6. Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A population-based propensity score matching analysis of risk factors and the impact on survival associated with refusal of cancer-directed surgery in patients with prostate cancer;Scientific Reports;2024-04-25

2. Urologist-level variation in the management of T1a renal cell carcinoma: A population-based cohort study;Urologic Oncology: Seminars and Original Investigations;2024-03

3. Use of Persuasive Language in Communication of Risk during Prostate Cancer Treatment Consultations;Medical Decision Making;2024-02-12

4. Association between urology practice use of multiparametric MRI and genomic testing and treatment of men with newly diagnosed prostate cancer;Urologic Oncology: Seminars and Original Investigations;2023-10

5. Explainable ML models for a deeper insight on treatment decision for localized prostate cancer;Scientific Reports;2023-07-17